Exagen amends ATM facility with I.B.6 float limitation; $50M capacity unchanged

EXAGEN INC.

Amendment adds General Instruction I.B.6 limit: sales capped at one-third of public float per any 12-month period while float below $75M.
Total at-the-market equity offering capacity remains at up to $50 million.
No shares have been sold under I.B.6 in the prior 12-month period ending Nov 17, 2023.
Amendment dated November 17, 2023, with TD Cowen (formerly Cowen and Company, LLC).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

EXAGEN INC. amended Amendment No. 1 to the Sales Agreement with Cowen and Company, LLC valued at up to $50,000,000 (effective 2023-11-17).

Action: amendment
Agreement: atm program
Counterparty: Cowen and Company, LLC
Value: up to $50,000,000
Effective: 2023-11-17

Exact text from the filing

On November 17, 2023, Exagen Inc. (the “Company”) entered into Amendment No. 1 (“Amendment No. 1”) to that certain sales agreement, dated September 15, 2022 (the “Sales Agreement”), by and between the Company and Cowen and Company, LLC (“TD Cowen”) in connection with the continuation of the Company’s at-the-market equity offering program (the “Program”).

View on SEC.gov

Browse all material agreements →

EXAGEN INC. filing history →

Source: SEC EDGAR

accession 0001274737-23-000105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.